Since ApoC-III levels are increased in CSF of AD’s patients, it has been hypothesized that ApoC-III on TRLs may promote the efflux of Amyloid β from the brain [73, 74], thus influencing the AD mechanisms of Aβ assembly and neural inflammation. The gene discussed is APOC3; the disease is Alzheimer disease.